- Home
- BCML vs FDMT Comparison
BCML vs FDMT Comparison
Compare BCML & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCML | FDMT |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 364.8M | 695.3M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BCML | FDMT |
|---|---|---|
| Price | $30.08 | $13.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $34.00 | $31.71 |
| AVG Volume (30 Days) | 45.3K | ★ 1.0M |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.09% | N/A |
| EPS Growth | 3.81 | ★ 18.79 |
| EPS | ★ 0.11 | N/A |
| Revenue | N/A | ★ $85,209,000.00 |
| Revenue This Year | $13.71 | N/A |
| Revenue Next Year | $5.25 | $70.28 |
| P/E Ratio | $273.27 | ★ N/A |
| Revenue Growth | N/A | ★ 230194.60 |
| 52 Week Low | $26.78 | $6.47 |
| 52 Week High | $34.98 | $16.93 |
Technical Indicators
Market Signals| Indicator | BCML | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 42.78 | 47.73 |
| Support Level | $29.57 | $8.43 |
| Resistance Level | $31.07 | $14.00 |
| Average True Range (ATR) | 0.68 | 0.92 |
| MACD | 0.06 | -0.26 |
| Stochastic Oscillator | 21.57 | 0.87 |
Price Performance
Historical ComparisonAbout BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).